Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV Infection

1 Jun 2005

Abstract excerpt

Human herpesviruses, including EBV, persist for life in infected individuals. During the lytic replicative cycle that is required for the production of infectious virus and transmission to another host, many viral Ags are expressed. Especially at this stage, immune evasion strategies are likely to be advantageous to avoid elimination of virus-producing cells. However, little is known about immune escape during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Cytomegalovirus and herpesvirus research
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15905524
DOI: 10.4049/jimmunol.174.11.6829

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV InfectionPMID 15905524Read ↗

Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen PresentationSemantic proximity Read ↗

Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.Semantic proximity Read ↗

Immune regulation in Epstein-Barr virus-associated diseasesSemantic proximity Read ↗

The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for DegradationSemantic proximity Read ↗

Cytotoxic CD4+ T Cell Responses to EBV Contrast with CD8 Responses in Breadth of Lytic Cycle Antigen Choice and in Lytic Cycle RecognitionSemantic proximity Read ↗

The Lytic Cycle of Epstein-Barr Virus Is Associated with Decreased Expression of Cell Surface Major Histocompatibility Complex Class I and Class II MoleculesSemantic proximity Read ↗

A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primatesSemantic proximity Read ↗

A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.Semantic proximity Read ↗

Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+KIR+CD56dim subsetsSemantic proximity Read ↗

Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a , in EBV-Positive Gastric CarcinomasSemantic proximity Read ↗

Persistent Epstein‐Barr virus infection in a human T‐cell line: unique program of latent virus expression.Semantic proximity Read ↗

The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-IISemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.